Management of pregnancy and lactation

Lisa R. Sammaritano, Bonnie Lee Bermas

Research output: Contribution to journalReview article

Abstract

Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child.

Original languageEnglish (US)
JournalBest Practice and Research: Clinical Rheumatology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Lactation
Mothers
Pregnancy Outcome
Rheumatic Diseases
Pregnancy
Autoimmune Diseases
Counseling
Safety
Therapeutics

Keywords

  • Antiphospholipid syndrome
  • Inflammatory arthritis
  • Lactation
  • Neonatal lupus erythematosus
  • Pregnancy
  • Rheumatic diseases
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology

Cite this

Management of pregnancy and lactation. / Sammaritano, Lisa R.; Bermas, Bonnie Lee.

In: Best Practice and Research: Clinical Rheumatology, 01.01.2019.

Research output: Contribution to journalReview article

@article{2560b75d28964b4ebb2e1ac2327fe8af,
title = "Management of pregnancy and lactation",
abstract = "Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child.",
keywords = "Antiphospholipid syndrome, Inflammatory arthritis, Lactation, Neonatal lupus erythematosus, Pregnancy, Rheumatic diseases, Systemic lupus erythematosus",
author = "Sammaritano, {Lisa R.} and Bermas, {Bonnie Lee}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.berh.2019.03.007",
language = "English (US)",
journal = "Best Practice and Research in Clinical Rheumatology",
issn = "1521-6942",
publisher = "Bailliere Tindall Ltd",

}

TY - JOUR

T1 - Management of pregnancy and lactation

AU - Sammaritano, Lisa R.

AU - Bermas, Bonnie Lee

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child.

AB - Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child.

KW - Antiphospholipid syndrome

KW - Inflammatory arthritis

KW - Lactation

KW - Neonatal lupus erythematosus

KW - Pregnancy

KW - Rheumatic diseases

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=85064165031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064165031&partnerID=8YFLogxK

U2 - 10.1016/j.berh.2019.03.007

DO - 10.1016/j.berh.2019.03.007

M3 - Review article

C2 - 31427053

AN - SCOPUS:85064165031

JO - Best Practice and Research in Clinical Rheumatology

JF - Best Practice and Research in Clinical Rheumatology

SN - 1521-6942

ER -